Adial Pharmaceuticals Inc (ADIL)
US Market

Adial Pharmaceuticals (ADIL) Financial Statements


Adial Pharmaceuticals Financial Overview

Adial Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-5.882; its P/E ratio is -0.26; Adial Pharmaceuticals is scheduled to report earnings on November 12, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Sep 23Jun 23Mar 23Dec 22
Income Statement-
Total Revenue$ 450.00K---$ 134.97K
Gross Profit$ 450.00K--$ 10.00K$ 664.97K
EBIT$ -1.24M$ -1.35M$ -1.51M$ -2.91M$ -2.92M
EBITDA$ -1.24M$ -1.35M$ -1.53M$ -2.89M$ -2.90M
Net Income Common Stockholders$ -1.92M$ -1.38M$ 1.09M$ 2.94M$ -2.87M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 2.83M$ 315.88K$ 1.22M$ 2.31M$ 4.00M
Total Assets$ 4.74M$ 2.87M$ 3.78M$ 3.90M$ 5.73M
Total Debt$ 0.00$ 0.00$ 0.00$ 699.80K$ 699.38K
Net Debt$ -2.83M$ -315.88K$ -1.22M$ -1.61M$ -3.30M
Total Liabilities$ 653.08K$ 528.18K$ 461.75K$ 2.46M$ 2.46M
Stockholders Equity$ 4.08M$ 2.34M$ 3.32M$ 1.44M$ 3.28M
Cash Flow-
Free Cash Flow$ -872.55K$ -1.04M$ -1.11M$ -2.29M$ -1.75M
Operating Cash Flow$ -1.22M$ -1.39M$ -1.91M$ -2.29M$ -1.75M
Investing Cash Flow$ 350.00K$ 350.00K$ 800.00K--
Financing Cash Flow$ 3.38M$ 138.67K$ 58.00$ 609.61K-
Currency in USD

Adial Pharmaceuticals Earnings and Revenue History

Adial Pharmaceuticals Debt to Assets

Adial Pharmaceuticals Cash Flow

Adial Pharmaceuticals Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis